JP2021527425A5 - - Google Patents
Info
- Publication number
- JP2021527425A5 JP2021527425A5 JP2020570748A JP2020570748A JP2021527425A5 JP 2021527425 A5 JP2021527425 A5 JP 2021527425A5 JP 2020570748 A JP2020570748 A JP 2020570748A JP 2020570748 A JP2020570748 A JP 2020570748A JP 2021527425 A5 JP2021527425 A5 JP 2021527425A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- receptor
- domain
- thrombopoietin
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024102884A JP2024156656A (ja) | 2018-06-21 | 2024-06-26 | キメラ増殖因子受容体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1810181.6 | 2018-06-21 | ||
| GBGB1810181.6A GB201810181D0 (en) | 2018-06-21 | 2018-06-21 | Cells expressing chimeric recominant growth factor receptors |
| PCT/GB2019/051745 WO2019243835A1 (en) | 2018-06-21 | 2019-06-21 | Chimeric growth factor receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102884A Division JP2024156656A (ja) | 2018-06-21 | 2024-06-26 | キメラ増殖因子受容体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527425A JP2021527425A (ja) | 2021-10-14 |
| JP2021527425A5 true JP2021527425A5 (https=) | 2022-06-24 |
Family
ID=63042840
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570748A Ceased JP2021527425A (ja) | 2018-06-21 | 2019-06-21 | キメラ増殖因子受容体 |
| JP2024102884A Abandoned JP2024156656A (ja) | 2018-06-21 | 2024-06-26 | キメラ増殖因子受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102884A Abandoned JP2024156656A (ja) | 2018-06-21 | 2024-06-26 | キメラ増殖因子受容体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20210205365A1 (https=) |
| EP (1) | EP3810646A1 (https=) |
| JP (2) | JP2021527425A (https=) |
| KR (1) | KR20210022690A (https=) |
| CN (1) | CN112601759A (https=) |
| AU (1) | AU2019289202B2 (https=) |
| BR (1) | BR112020026233A2 (https=) |
| CA (1) | CA3104079A1 (https=) |
| CL (1) | CL2020003319A1 (https=) |
| CO (1) | CO2020016052A2 (https=) |
| CR (1) | CR20200624A (https=) |
| EA (1) | EA202190100A1 (https=) |
| EC (1) | ECSP20082338A (https=) |
| GB (1) | GB201810181D0 (https=) |
| IL (1) | IL279469A (https=) |
| MX (1) | MX2020014257A (https=) |
| PH (1) | PH12020500678A1 (https=) |
| SG (1) | SG11202012726QA (https=) |
| WO (1) | WO2019243835A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
| GB201900858D0 (en) * | 2019-01-22 | 2019-03-13 | Price Nicola Kaye | Receptors providing targeted costimulation for adoptive cell therapy |
| BR112022011795A2 (pt) | 2019-12-20 | 2022-08-30 | Instil Bio Uk Ltd | Métodos para preparar e isolar uma população terapêutica de linfócitos e para tratar câncer em um indivíduo, população terapêutica de linfócitos, bolsa criopreservada, recipiente flexível, e, sistema para extração de linfócitos |
| EP4110355A1 (en) * | 2020-02-24 | 2023-01-04 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Nk cells or t cells expressing hematopoietic growth factor receptors and use for treating cancer |
| EP4263807A2 (en) | 2020-12-18 | 2023-10-25 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
| EP4262828A1 (en) | 2020-12-18 | 2023-10-25 | Instil Bio (Uk) Limited | Tumor infiltrating lymphocytes and anti-cd47 therapeutics |
| JP2023554425A (ja) | 2020-12-18 | 2023-12-27 | インスティル バイオ （ユーケイ） リミテッド | 腫瘍浸潤リンパ球の処理 |
| US20250288666A1 (en) | 2021-07-14 | 2025-09-18 | Synthekine, Inc. | Methods and compositions for use in cell therapy of neoplastic disease |
| WO2025076134A1 (en) * | 2023-10-03 | 2025-04-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nk cells or t cells expressing chimeric hematopoietic growth factor receptors and methods of use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69941126D1 (de) * | 1998-09-23 | 2009-08-27 | Zymogenetics Inc | Cytokinerezeptor zalpha11 |
| HK1047109A1 (zh) | 1999-10-15 | 2003-02-07 | University Of Massachusetts | 作为指定基因干预工具的rna干预轨迹基因 |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| AU2001275474A1 (en) | 2000-06-12 | 2001-12-24 | Akkadix Corporation | Materials and methods for the control of nematodes |
| US20030096339A1 (en) * | 2000-06-26 | 2003-05-22 | Sprecher Cindy A. | Cytokine receptor zcytor17 |
| US20140047572A1 (en) * | 2012-08-13 | 2014-02-13 | University Of Rochester | Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury |
| EP4166148B1 (en) * | 2014-06-06 | 2026-02-18 | Memorial Sloan-Kettering Cancer Center | Mesothelin-targeted chimeric antigen receptors and uses thereof |
| GB201522097D0 (en) * | 2015-12-15 | 2016-01-27 | Cellular Therapeutics Ltd | Cells |
| WO2018175476A1 (en) * | 2017-03-20 | 2018-09-27 | Baylor College Of Medicine | Transgenic c-mpl provides ligand-dependent co-stimulation and cytokine signals to tcr-engineered cells |
-
2018
- 2018-06-21 GB GBGB1810181.6A patent/GB201810181D0/en not_active Ceased
-
2019
- 2019-06-21 CA CA3104079A patent/CA3104079A1/en active Pending
- 2019-06-21 BR BR112020026233-1A patent/BR112020026233A2/pt not_active IP Right Cessation
- 2019-06-21 MX MX2020014257A patent/MX2020014257A/es unknown
- 2019-06-21 AU AU2019289202A patent/AU2019289202B2/en not_active Expired - Fee Related
- 2019-06-21 EP EP19739687.2A patent/EP3810646A1/en active Pending
- 2019-06-21 JP JP2020570748A patent/JP2021527425A/ja not_active Ceased
- 2019-06-21 CN CN201980055314.2A patent/CN112601759A/zh active Pending
- 2019-06-21 SG SG11202012726QA patent/SG11202012726QA/en unknown
- 2019-06-21 CR CR20200624A patent/CR20200624A/es unknown
- 2019-06-21 KR KR1020217001790A patent/KR20210022690A/ko not_active Withdrawn
- 2019-06-21 WO PCT/GB2019/051745 patent/WO2019243835A1/en not_active Ceased
- 2019-06-21 EA EA202190100A patent/EA202190100A1/ru unknown
-
2020
- 2020-12-15 IL IL279469A patent/IL279469A/en unknown
- 2020-12-17 US US17/124,922 patent/US20210205365A1/en not_active Abandoned
- 2020-12-18 EC ECSENADI202082338A patent/ECSP20082338A/es unknown
- 2020-12-18 PH PH12020500678A patent/PH12020500678A1/en unknown
- 2020-12-21 CL CL2020003319A patent/CL2020003319A1/es unknown
- 2020-12-21 CO CONC2020/0016052A patent/CO2020016052A2/es unknown
-
2024
- 2024-06-26 JP JP2024102884A patent/JP2024156656A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527425A5 (https=) | ||
| JP7689552B2 (ja) | 核酸ポリペプチド組成物およびその使用 | |
| JP7227290B2 (ja) | キメラ抗原受容体、組成物及び方法 | |
| Maus et al. | Making better chimeric antigen receptors for adoptive T-cell therapy | |
| JP7189155B2 (ja) | 癌関連障害の治療のためのキナゾリン－ピラゾール誘導体 | |
| CN103483452B (zh) | 双信号独立的嵌合抗原受体及其用途 | |
| CN109219445B (zh) | 嵌合抗原受体修饰细胞治疗癌症的应用 | |
| CN105331586B (zh) | 一种包含高效杀伤启动机制的肿瘤精准t细胞及其用途 | |
| JP6800141B2 (ja) | Ｉｌ−２およびインテグリン結合性ｆｃ融合タンパク質による相乗的な腫瘍処置 | |
| AU2014249405C1 (en) | Fusion immunomodulatory proteins and methods for making same | |
| JP2024500847A5 (https=) | ||
| KR20210020932A (ko) | Bcma 키메라 항원 수용체 및 이의 용도 | |
| CN114025787B (zh) | Car-t细胞的原位募集、重编程和释放 | |
| WO2015066262A1 (en) | Methods for preventing toxicity of adoptive cell therapy | |
| WO2017219934A1 (zh) | 一种高效稳定表达抗体的杀伤性细胞及其用途 | |
| JP2019513371A (ja) | 核酸ポリペプチド組成物とその使用 | |
| JP7842751B2 (ja) | 腫瘍溶解性ウイルスが有効なｔｉｌ療法のためにｔ細胞応答を強化する | |
| JP2022512538A5 (https=) | ||
| CN113195535A (zh) | 用于连接表达car的免疫细胞与抗原呈递细胞的双特异性多肽及其用途 | |
| WO2024113714A9 (zh) | 敲低nkg2a基因的car-免疫细胞及其用途 | |
| CN113272016A (zh) | 关于治疗实体肿瘤的工程化和非工程化γδ-T细胞的组合物和方法 | |
| CN110845621A (zh) | 一种靶向egfr和cd19双靶点的嵌合抗原受体方法 | |
| JP2023524995A5 (https=) | ||
| JP2021505190A5 (https=) | ||
| US20250388695A1 (en) | Epcam-cd3 epsilon bispecific antibodies |